XML 72 R44.htm IDEA: XBRL DOCUMENT v3.3.1.900

License and Collaboration Agreements (Details) - USD ($) $ in Millions	1 Months Ended				12 Months Ended
	Sep. 30, 2015	Jul. 31, 2014	Feb. 28, 2014	Mar. 31, 2013	Dec. 31, 2015	Dec. 31, 2013	Dec. 31, 2011	Dec. 31, 2009	Dec. 31, 2004	Nov. 30, 2015	Apr. 29, 2013
Respironics Agreement
Collaboration Agreements
Aggregate payment upon the achievement of certain clinical milestones										$ 7.6
Eleison License Agreement
Collaboration Agreements
License revenues							$ 1.0
Premacure License Agreement
Collaboration Agreements
License revenues						$ 11.5
License purchase option price				$ 11.5
Proceeds from sale of license											$ 11.5
CFFT
Collaboration Agreements
Compensation earned under research funding agreements with CFFT								$ 2.2	$ 1.7
Royalty payable on approval of ARIKAYCE as commercialized drug					$ 13.4
Royalty payment period					3 years
Period for meeting sales milestones for additional royalty payments					5 years
Royalty payable on meeting certain sales milestones					$ 3.9
Therapure
Collaboration Agreements
Initial term of contract manufacturing agreement			5 years
Period of each automatic renewal of contract manufacturing agreement			2 years
Written notice period required for termination of contract manufacturing agreement			2 years
Therapure | Minimum
Collaboration Agreements
Advance notice period for termination of contract manufacturing agreement by the entity			180 days
PARI Agreement
Collaboration Agreements
Initial term of contract manufacturing agreement		15 years
Additional term of contract manufacturing agreement		5 years
PARI Agreement | Minimum
Collaboration Agreements
Written notice period required for termination of contract manufacturing agreement		1 year
Fill/Finish Agreement
Collaboration Agreements
Minimum obligation	$ 2.7
Extension period	2 years
Period prior to expiration for extension	1 year

X

- Definition

Amount of royalty payments if entity meets certain milestones under a research and development agreement.

+ References

No definition available.

+ Details

Name:	insm_AdditionalRoyaltyGuaranteesCommitmentsAmount
Namespace Prefix:	insm_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Represents the additional extension period of contract manufacturing agreement.

+ References

No definition available.

+ Details

Name:	insm_AdditionalTermOfContractManufacturingAgreement
Namespace Prefix:	insm_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the advance notice period for termination of contract manufacturing agreement by the entity.

+ References

No definition available.

+ Details

Name:	insm_AdvanceNoticePeriodForTerminationOfContractManufacturingAgreementByTheEntity
Namespace Prefix:	insm_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the extension period under the terms of the agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	insm_CommercialServicesAgreementExtensionPeriod
Namespace Prefix:	insm_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the period prior to the expiration of the agreement in which an agreement for extension may be entered into upon mutual agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	insm_CommercialServicesAgreementExtensionPeriodPeriodPriorToExpirationForExtensionAgreement
Namespace Prefix:	insm_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the minimum obligation due under the terms of the agreement.

+ References

No definition available.

+ Details

Name:	insm_CommercialServicesAgreementMinimumObligation
Namespace Prefix:	insm_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Represents the initial period of contract manufacturing agreement.

+ References

No definition available.

+ Details

Name:	insm_InitialTermOfContractManufacturingAgreement
Namespace Prefix:	insm_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the option provided to the licensee to purchase a fully paid option for cash payment.

+ References

No definition available.

+ Details

Name:	insm_OptionPriceForLicense
Namespace Prefix:	insm_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Aggregate payment upon the achievement of certain clinical milestones.

+ References

No definition available.

+ Details

Name:	insm_PaymentsUponAchievementOfClinicalMilestonesAmount
Namespace Prefix:	insm_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Period for meeting sales milestones for additional royalty payments after the drug is commercialized.

+ References

No definition available.

+ Details

Name:	insm_PeriodForMeetingSalesMilestonesForAdditionalRoyaltyPayments
Namespace Prefix:	insm_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the period of each automatic renewal of contract manufacturing agreement.

+ References

No definition available.

+ Details

Name:	insm_PeriodOfEachAutomaticRenewalOfContractManufacturingAgreement
Namespace Prefix:	insm_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the amount received by the entity in sale of a fully paid license related to the entity's product(s).

+ References

No definition available.

+ Details

Name:	insm_ProceedsFromSaleOfLicense
Namespace Prefix:	insm_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Period for royalty payments under a research and development agreement.

+ References

No definition available.

+ Details

Name:	insm_RoyaltyPaymentPeriod
Namespace Prefix:	insm_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the written notice period required for termination of contract manufacturing agreement by either party.

+ References

No definition available.

+ Details

Name:	insm_WrittenNoticePeriodForTerminationOfContractManufacturingAgreement
Namespace Prefix:	insm_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Revenue from multiple-deliverable arrangements that include licensing fees and services revenue. Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Services revenue may be derived by providing other, nonspecified, services during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(d),(e))
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name:	us-gaap_LicenseAndServicesRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount the entity has committed to make for future royalty guarantees.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 928
-SubTopic 440
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6473578&loc=d3e63223-108013

+ Details

Name:	us-gaap_RoyaltyGuaranteesCommitmentsAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=insm_RespironicsAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=insm_EleisonPharmaceuticalsLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=insm_PremacureLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=insm_CysticFibrosisFoundationTherapeuticsIncCollaborationAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=insm_TherapureBiopharmaIncContractManufacturingAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=insm_PRIPharmaGmbhCommercializationAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=insm_CommercialFilVFinishServicesAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: